Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Shared Decision Making in Hemophilia Patient CareRelease Date:Quality Improvement Rare Disease China Optimizing HRRm Testing and Workflow Integration in mCSPCRelease Date:Quality Improvement, Research Oncology Canada Driving Timely Biomarker Testing to Optimize Treatment Decisions for Colorectal Cancer Patients Across CanadaRelease Date:Partner: Colorectal Cancer Canada (CCC)Quality Improvement, Research Oncology Canada Optimizing Disease Management to Improve Alopecia Areata Quality of CareRelease Date:Quality Improvement Inflammation & Immunology China Providing Appropriate Medical Care for IBD PatientsRelease Date:Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD)Quality Improvement Inflammation & Immunology Japan Fostering Educational Initiatives for ALK+ Metastatic Non-Small Cell Lung Cancer(mNSCLC) Tyrosine Kinase Inhibitors(TKI) TherapyRelease Date:Education Oncology Canada 2026 Headache Medicine Fellowship - USRelease Date:Fellowship Internal Medicine USA Advances in Migraine ManagementRelease Date:Education Internal Medicine USA Real-World Evidence of SUL-DUR on Special Populations with CRAB InfectionRelease Date:Research Inflammation & Immunology China Optimizing Atopic Dermatitis Quality of Care and Best Practice at Local LevelRelease Date:Quality Improvement Inflammation & Immunology China Addressing HCP Knowledge Gaps in Baseline Assessments for Adults with Ulcerative Colitis Starting S1P Receptor Modulator TherapyRelease Date:Education Inflammation & Immunology USA Use of AI to Improve Speed/Precision of Treatment Selection & Clinical Management for Patients w/ Invasive Mold InfectionsRelease Date:Education Hospital Australia, China, France, Germany, Italy, Korea, Spain, Taiwan, United Kingdom Quality improvement strategies to enhance quality of life in ALK-positive lung cancer patientsRelease Date:Quality Improvement Oncology Spain Maintenance Therapy in HER2+ Metastatic Breast Cancer (MBC)Release Date:Education Oncology USA Efforts to Improve Quality of Migraine CareRelease Date:Partner: The Japanese Headache SocietyQuality Improvement Internal Medicine Japan Enhancing HCP Education in Adult Vaccination against Respiratory InfectionsRelease Date:Education Vaccines Austria, Belgium, Greece, Ireland, Luxembourg, Portugal, Switzerland Migraine and Women’s HealthQuality Improvement, Research Internal Medicine USA Real World Evidence on clinical outcomes with Aztreonam-Avibactam (ATM-AVI)Release Date:Research Inflammation & Immunology All Improving Health Outcomes in Patients with ATTR-CM Through the Development of a Shared Decision-Making Tool (Decision Aid)Release Date:Research Rare Disease USA Capacity Building for Clinical Trials in Sickle Cell Disease (SCD) - Education for Healthcare ProfessionalsRelease Date:Education Rare Disease USA Prostate Cancer: Best Practices for Combining Targeted Therapies in mPCRelease Date:Education Oncology USA Transthyretin Cardiac Amyloidosis FellowshipRelease Date:Research Rare Disease USA Optimizing Adult Vaccination Ecosystem in IndiaRelease Date:Quality Improvement Vaccines India Evidence Based Safety Contextualization of JAK inhibitors in the Treatment of Moderate to Severe Atopic DermatitisRelease Date:Education Inflammation & Immunology China, France, Germany, Italy, Japan, Korea, Spain, USA Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple MyelomaRelease Date:Research Oncology Spain Optimizing Clinical Care Delivery for Patients with Multiple Myeloma Receiving Bispecific AntibodiesRelease Date:Quality Improvement Oncology All Enhancing HCP Education in Maternal VaccinationRelease Date:Education Vaccines Saudi Arabia Diagnosis and Treatment of Cancer CachexiaRelease Date:Education Oncology All Evidence-Based Education on the Potential Impact of a Generic JAK Inhibitor on the Management of Rheumatologic DiseasesRelease Date:Education Inflammation & Immunology USA B-cell Maturation Antigen (BCMA) Bi-Specific Antibodies (BsAbs) in Relapsed/Refractory Multiple Myeloma (RRMM)Release Date:Education Oncology USA Education on Mechanism of Action of JAK3 and TEC Family Kinase Role in Alopecia AreataRelease Date:Education Inflammation & Immunology USA 2026 Hemophilia Fellowship – United StatesRelease Date:Fellowship Rare Disease All Pediatric Pneumococcal Disease and Serotype Distribution: Surveillance Studies in Saudi ArabiaRelease Date:Research Vaccines Saudi Arabia Optimising Ulcerative Colitis Care: Bridging Knowledge Gaps, Integrating Biomarker-Based Strategies, and Advancing EquityRelease Date:Education Inflammation & Immunology Australia Surveillance of Pneumococcal Disease Serotype Distribution in Pediatric and Adult Pneumococcal Disease in TürkiyeRelease Date:Research Vaccines Turkey Surveillance of Pneumococcal Disease Serotype Distribution in Pediatric and Adult Pneumococcal Disease in TürkiyeRelease Date:Research Vaccines Turkey Title Grant Type Focus Area Country Application Due Date Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)Release Date:Education Rare Disease USA Quality Improvement Grants to improve the early suspicion, identification, and the management of patients with ATTR-CMRelease Date:Quality Improvement Rare Disease Canada Develop Young Physicians to Lead the Increase in Preventive Awareness by VaccinationRelease Date:Education Vaccines Japan Optimizing maternal immunization practice and vaccination access during pregnancy in ItalyRelease Date:Quality Improvement Vaccines Italy Projects for Enhancing Regional Cancer TreatmentRelease Date:Partner: Japanese Society of Clinical OncologyQuality Improvement Oncology Japan Sickle Cell Disease (SCD) FellowshipRelease Date:Fellowship Rare Disease USA Cancer RegistryRelease Date:Research Oncology Congo, The Democratic Republic The Value of Standardized Diagnosis and Treatment in Patients with Moderate-to-Severe Atopic DermatitisRelease Date:Research Inflammation & Immunology China Real World Evidence of Abrocitinib in Adolescent Patients with Moderate-to-Severe Atopic DermatitisRelease Date:Research Inflammation & Immunology China Improving the Therapeutic Environment for Metastatic Breast CancerRelease Date:Education Oncology Japan Shared Decision-Making (SDM) in Lung CancerRelease Date:Education Oncology Japan Improving Care for Patients with Hodgkin and Non-Hodgkin’s LymphomaRelease Date:Education Oncology USA New Mechanisms and Emerging Treatment Options in Metastatic Breast CancerEducation Oncology All Addressing Knowledge Gaps in Aplastic AnemiaRelease Date:Education Hospital All Gene and Gene-modified Cell Therapies Medical EducationRelease Date:Partner: American Society of Gene + Cell TherapyEducation Rare Disease All Education for Improvement of Early Detection and Appropriate Anticoagulant Therapy for Atrial FibrillationRelease Date:Education Internal Medicine Japan Efforts to Improve Quality of Migraine Medical CareRelease Date:Partner: The Japanese Headache SocietyEducation Internal Medicine Japan Pathological diagnosis and Immunohistochemistry biomarker assessments of Breast CancerRelease Date:Quality Improvement Oncology Ghana Evolving Treatment Options in First-line Metastatic Urothelial Carcinoma (mUC) and Muscle Invasive Bladder Cancer (MIBC)Education Oncology All Promoting Understanding of COVID-19 and Vaccination and Improving Communication Skills for Healthcare ProfessionalsRelease Date:Quality Improvement Vaccines Japan American Headache Society Quality Improvement Competitive Grant ProgramQuality Improvement Internal Medicine USA Boosting Oncology Opportunities for Support programs and Treatment, (BOOST), An Oncology Quality Boosting ProgramRelease Date:Quality Improvement Oncology Netherlands Understanding the Mechanisms and Formulating the Optimal Management of Hematological Toxicity of PARPiRelease Date:Partner: National Comprehensive Cancer NetworkResearch Oncology USA Improving Care for Patients with Recurrent/Metastatic (R/M) Cervical CancerRelease Date:Education Oncology USA Enhancing HCPs’ Preparedness: Maternal Immunization Knowledge UpdatesRelease Date:Education Vaccines USA Real-World Clinical Outcomes Among Adult and Adolescent Patients with Severe Alopecia Areata Receiving Ritlecitinib in ChinaRelease Date:Research Inflammation & Immunology China Education on the Appropriate Diagnosis and Treatment of Overactive Bladder or Neurogenic BladderRelease Date:Education Internal Medicine Japan Interventional Research Studies with ElranatamabRelease Date:Research Oncology All Research in Ulcerative Colitis (UC) 2024Release Date:Research Inflammation & Immunology Brazil, India, Mexico, Saudi Arabia, Taiwan, Turkey Advances in the Management of Ulcerative Colitis (UC)Release Date:Education Inflammation & Immunology All Research in Ulcerative Colitis (UC) 2024Release Date:Research Inflammation & Immunology Australia, Austria, Belgium, Canada, Czech Republic, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Spain, Switzerland, United Kingdom Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple MyelomaRelease Date:Research Oncology USA BCMA-Directed Bispecific Antibody Treatment in Multiple MyelomaRelease Date:Education Oncology Japan Research on MBL producing Enterobacterales and/or Stenotrophomonas maltophiliaRelease Date:Research Hospital Austria, Brazil, China, France, Germany, Greece, India, Italy, Mexico, Saudi Arabia, Spain, Taiwan, Turkey, United Kingdom Increase Awareness & Understanding of Emerging Hemophilia Treatment Options (Global excluding United States)Release Date:Education Rare Disease All Optimal management of patients with prostate cancer receiving androgen deprivation therapy (ADT)Education Oncology USA Improving the Outpatient Management of Emergency Department Patients with Venous Thromboembolism (VTE)Release Date:Partner: American College of Emergency Physicians (ACEP)Quality Improvement Internal Medicine USA HER2 Expression in Urothelial Carcinoma (UC)Release Date:Education Oncology All Antimicrobial Resistance Testing & Stewardship to Improve Hospitalized Patients’ Health OutcomesRelease Date:Quality Improvement Hospital Benin, Congo, The Democratic Republic Closing the Knowledge Gap in anti-TNF Cycling in Rheumatoid ArthritisRelease Date:Education Inflammation & Immunology USA Increasing Healthcare Professional Skills For COVID-19 Vaccine Discussions That Advocate VaccinationRelease Date:Education Vaccines USA Community Oncology Support for Therapy Management in Multiple Myeloma (MM)Release Date:Education Oncology USA Management of Adults and Adolescents with Alopecia AreataRelease Date:Education Inflammation & Immunology USA Sickle Cell Disease Transition in CareRelease Date:Partner: National Alliance of Sickle Cell CentersQuality Improvement Rare Disease USA 2025 Rheumatology Fellowship – United StatesRelease Date:Fellowship Inflammation & Immunology USA Closing the Knowledge Gap in the Diagnosis and Management of Idiopathic Inflammatory Myopathies (IIM)Release Date:Education Inflammation & Immunology USA Invasive Mold Diseases (IMD) & Treatment OutcomesRelease Date:Research Hospital Australia, Austria, Belgium, China, France, Germany, Greece, Italy, Korea, Netherlands, Spain, Switzerland, United Kingdom Implementing Updated RSV Immunization Recommendations for Older AdultsRelease Date:Education Vaccines USA